CLRB Stock Analysis: Buy, Sell, or Hold?
$1.16
-0.05 (-4.13%)
▼
5d:
+0.87%
30d:
-1.69%
90d:
-55.38%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
41/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.15 – $1.41
Position: SLIGHTLY LOW
Forward P/E & Valuation
-0.6x
Next 12M consensus est.
Wall Street Target
$11.50
+891.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.11 / $1.37
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
ℹ️ NEUTRAL: CLRB is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When CLRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CLRB is currently trading at $1.16, which is considered slightly low relative to its 30-day fair value range of $1.15 to $1.41.
Technical Outlook: Technically, CLRB is in a strong downtrend. Immediate support is located at $1.11, while resistance sits at $1.37. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $11.50 (+891.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLRB is in a strong downtrend. Immediate support is located at $1.11, while resistance sits at $1.37. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $11.50 (+891.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.15 -
$1.41
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$1.15 -
$1.41
Current vs Trading Range
SLIGHTLY LOW
Support Level
$1.11
Resistance Level
$1.37
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.1%)
- BULLISH: Trading 891.4% below Wall St target ($11.50)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.58
Wall Street Target
$11.50
(+891.4%)
Share CLRB Analysis
Share this live CLRB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CLRB)
Bearish
4 Retail Mentions
Reddit / WSB Comments
3
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Cellectar Biosciences (CLRB) reported progress on its lead asset, iopofosine I-131, in a Q3 earnings call, anticipating potential U.S. approval for Waldenström's macroglobulinemia as early as late 2027 or early 2028.
Key Retail Themes:
Company progress
Regulatory approval
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 6:40 PM ET
Data refreshes hourly during market hours. Next update: 7:40 PM
Data refreshes hourly during market hours. Next update: 7:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CLRB Research Pages
